FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic.

Authors :: Taylor, Nick Paul
Source :: FierceBiotech; 5/13/2022, pN.PAG-N.PAG, 1p
Publication Year :: 2022
Abstract: Editas Medicine has picked up more regulatory privileges [ABSTRACT FROM AUTHOR]

Subjects :: ORPHAN drugs
CELLULAR therapy
DRUG therapy
THALASSEMIA
BETA-Thalassemia
CLINICS

Tools